vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and OIL STATES INTERNATIONAL, INC (OIS). Click either name above to swap in a different company.

OIL STATES INTERNATIONAL, INC is the larger business by last-quarter revenue ($178.5M vs $121.8M, roughly 1.5× Core Laboratories Inc.). Core Laboratories Inc. runs the higher net margin — 4.2% vs -65.7%, a 69.9% gap on every dollar of revenue. On growth, OIL STATES INTERNATIONAL, INC posted the faster year-over-year revenue change (8.4% vs -1.4%). OIL STATES INTERNATIONAL, INC produced more free cash flow last quarter ($47.1M vs $517.0K). Over the past eight quarters, OIL STATES INTERNATIONAL, INC's revenue compounded faster (3.3% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Oil States International, Inc. is an American multinational corporation. It focuses on providing services to oil and gas companies. It is a public company listed on the New York Stock Exchange.

CLB vs OIS — Head-to-Head

Bigger by revenue
OIS
OIS
1.5× larger
OIS
$178.5M
$121.8M
CLB
Growing faster (revenue YoY)
OIS
OIS
+9.9% gap
OIS
8.4%
-1.4%
CLB
Higher net margin
CLB
CLB
69.9% more per $
CLB
4.2%
-65.7%
OIS
More free cash flow
OIS
OIS
$46.6M more FCF
OIS
$47.1M
$517.0K
CLB
Faster 2-yr revenue CAGR
OIS
OIS
Annualised
OIS
3.3%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
OIS
OIS
Revenue
$121.8M
$178.5M
Net Profit
$5.1M
$-117.2M
Gross Margin
10.9%
Operating Margin
1.5%
-63.7%
Net Margin
4.2%
-65.7%
Revenue YoY
-1.4%
8.4%
Net Profit YoY
-873.2%
EPS (diluted)
$0.11
$-1.99

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
OIS
OIS
Q1 26
$121.8M
Q4 25
$138.3M
$178.5M
Q3 25
$134.5M
$165.2M
Q2 25
$130.2M
$165.4M
Q1 25
$123.6M
$159.9M
Q4 24
$129.2M
$164.6M
Q3 24
$134.4M
$174.3M
Q2 24
$130.6M
$186.4M
Net Profit
CLB
CLB
OIS
OIS
Q1 26
$5.1M
Q4 25
$4.9M
$-117.2M
Q3 25
$14.2M
$1.9M
Q2 25
$10.6M
$2.8M
Q1 25
$-154.0K
$3.2M
Q4 24
$7.4M
$15.2M
Q3 24
$11.7M
$-14.3M
Q2 24
$9.0M
$1.3M
Gross Margin
CLB
CLB
OIS
OIS
Q1 26
Q4 25
20.8%
10.9%
Q3 25
22.0%
22.1%
Q2 25
20.3%
24.2%
Q1 25
19.5%
23.3%
Q4 24
17.8%
23.7%
Q3 24
20.5%
21.7%
Q2 24
21.2%
23.8%
Operating Margin
CLB
CLB
OIS
OIS
Q1 26
1.5%
Q4 25
11.5%
-63.7%
Q3 25
15.6%
2.9%
Q2 25
11.7%
3.2%
Q1 25
3.6%
3.5%
Q4 24
11.0%
11.2%
Q3 24
14.7%
-6.3%
Q2 24
12.3%
1.1%
Net Margin
CLB
CLB
OIS
OIS
Q1 26
4.2%
Q4 25
3.6%
-65.7%
Q3 25
10.6%
1.2%
Q2 25
8.2%
1.7%
Q1 25
-0.1%
2.0%
Q4 24
5.7%
9.2%
Q3 24
8.7%
-8.2%
Q2 24
6.9%
0.7%
EPS (diluted)
CLB
CLB
OIS
OIS
Q1 26
$0.11
Q4 25
$0.11
$-1.99
Q3 25
$0.30
$0.03
Q2 25
$0.22
$0.05
Q1 25
$0.00
$0.05
Q4 24
$0.15
$0.24
Q3 24
$0.25
$-0.23
Q2 24
$0.19
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
OIS
OIS
Cash + ST InvestmentsLiquidity on hand
$22.8M
$69.9M
Total DebtLower is stronger
$1.7M
Stockholders' EquityBook value
$275.1M
$573.2M
Total Assets
$587.7M
$883.4M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
OIS
OIS
Q1 26
$22.8M
Q4 25
$22.7M
$69.9M
Q3 25
$25.6M
$67.1M
Q2 25
$31.2M
$53.9M
Q1 25
$22.1M
$66.8M
Q4 24
$19.2M
$65.4M
Q3 24
$21.5M
$46.0M
Q2 24
$17.7M
$25.2M
Total Debt
CLB
CLB
OIS
OIS
Q1 26
Q4 25
$110.3M
$1.7M
Q3 25
$114.1M
$1.9M
Q2 25
$124.6M
$1.9M
Q1 25
$124.4M
$124.7M
Q4 24
$126.1M
$124.7M
Q3 24
$139.9M
$124.6M
Q2 24
$147.6M
$124.3M
Stockholders' Equity
CLB
CLB
OIS
OIS
Q1 26
$275.1M
Q4 25
$266.0M
$573.2M
Q3 25
$271.3M
$689.0M
Q2 25
$261.3M
$690.6M
Q1 25
$253.4M
$683.4M
Q4 24
$246.6M
$680.7M
Q3 24
$250.7M
$684.8M
Q2 24
$240.3M
$690.4M
Total Assets
CLB
CLB
OIS
OIS
Q1 26
$587.7M
Q4 25
$584.0M
$883.4M
Q3 25
$591.4M
$1.0B
Q2 25
$602.1M
$993.7M
Q1 25
$591.5M
$990.7M
Q4 24
$585.1M
$1.0B
Q3 24
$600.5M
$994.1M
Q2 24
$597.8M
$1.0B
Debt / Equity
CLB
CLB
OIS
OIS
Q1 26
Q4 25
0.41×
0.00×
Q3 25
0.42×
0.00×
Q2 25
0.48×
0.00×
Q1 25
0.49×
0.18×
Q4 24
0.51×
0.18×
Q3 24
0.56×
0.18×
Q2 24
0.61×
0.18×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
OIS
OIS
Operating Cash FlowLast quarter
$4.0M
$50.1M
Free Cash FlowOCF − Capex
$517.0K
$47.1M
FCF MarginFCF / Revenue
0.4%
26.4%
Capex IntensityCapex / Revenue
1.7%
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$73.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
OIS
OIS
Q1 26
$4.0M
Q4 25
$7.9M
$50.1M
Q3 25
$8.5M
$30.7M
Q2 25
$13.9M
$15.0M
Q1 25
$6.7M
$9.3M
Q4 24
$20.6M
$18.2M
Q3 24
$13.1M
$28.8M
Q2 24
$17.1M
$10.2M
Free Cash Flow
CLB
CLB
OIS
OIS
Q1 26
$517.0K
Q4 25
$5.0M
$47.1M
Q3 25
$6.5M
$22.0M
Q2 25
$10.4M
$4.7M
Q1 25
$3.9M
$137.0K
Q4 24
$17.4M
$4.0M
Q3 24
$10.4M
$21.4M
Q2 24
$14.3M
$4.5M
FCF Margin
CLB
CLB
OIS
OIS
Q1 26
0.4%
Q4 25
3.6%
26.4%
Q3 25
4.8%
13.3%
Q2 25
8.0%
2.8%
Q1 25
3.1%
0.1%
Q4 24
13.4%
2.4%
Q3 24
7.7%
12.3%
Q2 24
10.9%
2.4%
Capex Intensity
CLB
CLB
OIS
OIS
Q1 26
Q4 25
2.1%
1.7%
Q3 25
1.5%
5.3%
Q2 25
2.7%
6.2%
Q1 25
2.3%
5.7%
Q4 24
2.5%
8.6%
Q3 24
2.0%
4.3%
Q2 24
2.2%
3.1%
Cash Conversion
CLB
CLB
OIS
OIS
Q1 26
0.77×
Q4 25
1.61×
Q3 25
0.60×
16.15×
Q2 25
1.31×
5.33×
Q1 25
2.94×
Q4 24
2.78×
1.20×
Q3 24
1.12×
Q2 24
1.90×
7.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

OIS
OIS

Project Driven$112.6M63%
Downhole Technologies$32.1M18%
Completion And Production Services$23.1M13%
Military And Other Products$10.7M6%

Related Comparisons